# FDA recall D-0444-2025

> **AsttraZeneca Pharmaceuticals LP** · Class II · drug recall initiated 2025-05-14.

## Product

Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .

## Reason for recall

Defective delivery system

## Distribution

USA Nationwide

## Key facts

- **Recall number:** D-0444-2025
- **Recalling firm:** AsttraZeneca Pharmaceuticals LP
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-05-14
- **Report date:** 2025-05-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Wilmington, DE, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0444-2025

## Citation

> AI Analytics. FDA recall D-0444-2025. Retrieved 2026-08-03 from https://api.ai-analytics.org/recall/D-0444-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*